Abstract.
The highly conserved Notch signaling pathway plays pleiotropic roles during embryonic development and is important for the regulation of selfrenewing tissues. The physiological functions of this signaling cascade range from stem cell maintenance and influencing cell fate decisions of barely differentiated progenitor cells, to the induction of terminal differentiation processes, all of which have been found to be recapitulated in different forms of cancers. Although Notch signaling has mostly been associated with oncogenic and growth-promoting roles, depending on the tissue type it can also function as a tumor suppressor. Here we describe recent findings on Notch signaling in cancer and tumor angiogenesis, and highlight some of the therapeutic approaches that are currently being developed to interfere with tumor growth and progression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Change history
21 March 2008
An Erratum to this paper has been published: https://doi.org/10.1007/s00018-008-8000-y
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 2 April 2007; received after revision 29 June 2007; accepted 2 July 2007
Rights and permissions
About this article
Cite this article
Koch, U., Radtke, F. Notch and cancer: a double-edged sword. Cell. Mol. Life Sci. 64, 2746–2762 (2007). https://doi.org/10.1007/s00018-007-7164-1
Published:
Issue date:
DOI: https://doi.org/10.1007/s00018-007-7164-1